The recent round of regulatory changes (LDTI, IFRS17, PBR) has put a demand on actuarial organizations, and, in particular, financial reporting functions unlike most have experienced in their careers. With adoption, where does this leave the financial reporting function going forward? What work is left to be done? How will the financial reporting function need to evolve under these accounting regimes? We will explore these topics and more as we moderate a debate, inclusive of the following questions:
- What are the biggest 'day two' items that remains on your organization's 'to-do' list?
- How are valuation actuaries equipped to navigate the newly available data, understand the results, and tell the underlying earnings story?
- How do new regulatory requirements fit into current close calendar requirements?
- What are the peripheral impacts from regulatory change (e.g., FP&A, product development) and how are your valuation actuaries involved in these processes?